Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Carriers01:24

Electron Carriers

91.7K
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
91.7K
Carrier Transport01:21

Carrier Transport

941
The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices.
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
941
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

4.3K
ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
4.3K
Carrier Generation and Recombination01:22

Carrier Generation and Recombination

1.3K
Carrier generation is the process by which electron-hole pairs (EHPs) are created within the semiconductor. In direct-bandgap semiconductors, such as gallium arsenide (GaAs), this occurs efficiently when energy absorption prompts valence electrons to leap into the conduction band, leaving behind holes.
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...
1.3K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.3K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.3K
Therapeutic Index01:13

Therapeutic Index

6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Possible Gastroenterological Causes of FUO (Fever of Unknown Origin).

Journal of clinical medicine·2026
Same author

Procalcitonin Levels in ICU Patients with SARS-CoV-2-Associated Viral Sepsis.

Journal of clinical medicine·2026
Same author

COVID-19 Impact on Lipid Profile and Metabolome in Patients with Type 2 Diabetes Mellitus: Mini-Review.

Current diabetes reviews·2026
Same author

Divergent Trends in Insect Disturbance Across Europe's Temperate and Boreal Forests.

Global change biology·2025
Same author

Tenascin-C and Thrombospondin-1 as a Potential Link Between Sleep Bruxism and Cardiovascular Diseases-A Case-Control Study.

Journal of clinical medicine·2025
Same author

The role of protease-activated receptors (PARs) in the functioning of platelets and platelet-derived microparticles (PMPs).

Frontiers in molecular biosciences·2025

Related Experiment Video

Updated: Jan 29, 2026

Multifunctional Hybrid Fe2O3-Au Nanoparticles for Efficient Plasmonic Heating
08:04

Multifunctional Hybrid Fe2O3-Au Nanoparticles for Efficient Plasmonic Heating

Published on: February 20, 2016

14.2K

Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics.

Bogusława Konopska1, Janusz Sokołowski2, Anna Woźniak3

  • 1Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Pharmaceutics
|January 28, 2026
PubMed
Summary

Human serum albumin (HSA) nanoparticles offer advanced drug delivery for cancer therapy. These albumin-based systems show promise in targeted drug transport, imaging, and theranostics for improved patient outcomes.

Keywords:
albumindrug delivery systemsnanoparticlestheranostics

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.5K

Related Experiment Videos

Last Updated: Jan 29, 2026

Multifunctional Hybrid Fe2O3-Au Nanoparticles for Efficient Plasmonic Heating
08:04

Multifunctional Hybrid Fe2O3-Au Nanoparticles for Efficient Plasmonic Heating

Published on: February 20, 2016

14.2K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.5K
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.5K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Effective drug delivery is crucial for modern medicine, requiring enhanced transport to target tissues.
  • Human serum albumin (HSA) is a well-established carrier for therapeutic nanoparticles, with several FDA-approved applications.
  • Albumin-based systems have demonstrated success in treating various cancers and in diagnostic imaging.

Purpose of the Study:

  • To review recent advancements in albumin-based nanoparticles for drug delivery, targeting, and imaging in cancer therapy.
  • To discuss synthesis and surface modification methods for albumin nanocarriers.
  • To highlight the potential of albumin in multimodal theranostic platforms for improved cancer treatment.

Main Methods:

  • Review of current literature on albumin-based nanoparticles.
  • Discussion of synthesis and surface modification techniques for nanocarriers.
  • Exploration of theranostic applications combining drug delivery, targeting, and imaging.

Main Results:

  • Albumin nanoparticles demonstrate significant potential for targeted drug delivery and improved pharmacokinetic properties.
  • Approved albumin-based drugs like Abraxane show efficacy in treating metastatic breast cancer and lung carcinoma.
  • Emerging theranostic platforms utilizing albumin show promise for multimodal cancer treatment.

Conclusions:

  • Albumin-based nanoparticles represent a versatile platform for advanced drug delivery, imaging, and theranostics in oncology.
  • Surface modification of albumin nanocarriers can enable targeted delivery to pathological sites.
  • Albumin's unique properties position it as a key component in the future of personalized cancer therapy.